Alterations in metaphase durations in cells derived from human tumours

Area of Science:

• Cell Biology
• Cancer Research
• Biochemistry

Background:

• Previous studies indicated prolonged metaphase durations in SV40-transformed human fibroblasts.
• This observation suggested a potential link to increased mitotic indices in advanced tumors.
• Inconsistencies in the literature and a lack of data from malignant carcinomas necessitated further investigation.

Purpose of the Study:

• To investigate metaphase durations in various human cancer cells, including cervical dysplasias and malignant carcinomas.
• To compare these durations with non-cancerous human cell types.
• To explore potential underlying metabolic alterations contributing to observed cell cycle changes in tumors.

Main Methods:

• Time-lapse cinemicrography was employed to observe and measure cell division dynamics.
• Data were collected from various human cell types, including normal cells, cervical dysplasias, carcinoma in situ, and malignant carcinomas.
• Metaphase durations and cytokinesis progression were quantitatively analyzed.

Main Results:

• Mean metaphase durations were significantly prolonged in cells derived from most malignant carcinomas studied.
• Cells from cervical dysplasias and carcinoma in situ did not exhibit prolonged metaphase durations.
• Cytokinesis appeared to progress more rapidly than normal in most tumor-derived cells.

Conclusions:

• Prolonged metaphase durations are a characteristic feature of many malignant carcinomas, but not all tumor-derived or pre-cancerous cells.
• Observed cell cycle alterations suggest a common metabolic change in tumor cells.
• A working hypothesis proposes that altered calcium regulation, possibly linked to mitochondrial metabolism, underlies these tumor-specific cell division changes.